Public Company News

Supermicro Announces Upcoming X14 Server Family with Future Support for the Intel® Xeon® 6 processor with Early Access Programs

Supermicro's Extensive Portfolio of Systems Offers the Flexibility to Match Today's Demand for Workload Optimized and Liquid Cooled Data Centers and Incorporates the New Efficient-core and Performance-core Processors – Rack Scale Plug and Play Solutions for AI Factories, Enterprise/Cloud Workload...

2024-04-10 01:00 4165

PROMISE Technology Unveils Pegasus M8 Storage Solution with Thunderbolt™ 5 technology at NAB 2024

Pegasus M8 is the fastest Pegasus RAID solution with the latest connectivity standard from Intel Corporation, delivering up to 3x more bandwidth LAS VEGAS and TAIPEI, April 10, 2024 /PR Newswire/ -- Ahead of NAB 2024, PROMISE Technology, a leading global provider of streaming data storage soluti...

2024-04-10 00:00 5742

Sunyard Preview for Transact 2024: Introducing the Sunyard Payment Ecosystem

HANGZHOU, China, April 9, 2024 /PRNewswire/ -- Sunyard Technology, the leading global payment solution provider, will showcase its new solutions and full series of remarkable products at the ETA Transact held at Mandalay Bay inLas Vegas from April 17 to 19, one of the top payment industry expos i...

2024-04-09 22:00 2914

Datasea Announces Intent of its CEO to Purchase Up $3,000,000 of its Common Stock in Open Market Purchases

BEIJING, April 9, 2024 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or the "Company"), a digital technology company incorporated inNevada, dedicated to innovative business in acoustic high tech and 5G-Artificial Intelligence multimodal communication technology inthe United States and Ch...

2024-04-09 22:00 4985

FLJ GROUP LIMITED RECEIVES NASDAQ MINIMUM BID PRICE DEFICIENCY NOTICE

SHANGHAI, April 9, 2024 /PRNewswire/ -- FLJ Group Limited (NASDAQ:FLJ) (the "Company"), today announced that it has received a notice from the Nasdaq Stock Market LLC ("Nasdaq") datedApril 3, 2024 stating that the Company is not in compliance with the requirement to maintain a minimum bid price o...

2024-04-09 21:00 4512

Taoping Reports Record 1Q 2024 Contract Revenue with 53% Increase Compared to 1Q 2023

SHENZHEN, China, April 9, 2024 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company"), a developer of innovative smart cloud platform services and solutions, new media and artificial intelligence solutions, today reported a total contract revenue value ofRMB 60.1 million (approximately USD $8...

2024-04-09 20:50 4854

Hitek Global Inc. Announces Fiscal Year 2023 Financial Results

XIAMEN, China, April 9, 2024 /PRNewswire/ -- Hitek Global Inc. (Nasdaq: HKIT) (the "Company"), a China-based information technology consulting and solutions service provider, today announced its financial results for the fiscal year endedDecember 31, 2023. Ms. Xiaoyang Huang, Chief Executive Off...

2024-04-09 20:30 5053

LG Innotek CEO Moon Hyuksoo aims to be the top in ADAS sensing by using 'High Performance LiDAR'.

* Overcoming limitations of existing LiDAR with Shortwave Infrared Rays...Detection range tripled * Various line-ups tailored to customers...Secured differentiated capacity by acquiring Argo patents * "Aiming to become No.1 in sensing solution for ADAS based on top-tier DNA in optics" SEOUL...

2024-04-09 20:00 2776

YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine

GAITHERSBURG, Md., April 9, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...

2024-04-09 20:00 2701

Jacobio Pharma to Present Data of PARP7 Inhibitor and P53 Reactivator at the 2024 AACR Annual Meeting

BEIJING, SHANGHAI, and SAN DIEGO, April 9, 2024 /PRNewswire/ -- Jacobin Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, today announced that the company will present the results of two preclinical evaluation of PARP7 inhibitor JAB-26766 and p53 Y220C reactivat...

2024-04-09 19:59 3136

Iridium Signs Five-Year Contract with L3Harris to Protect FAA Critical Infrastructure

Latest deployment of Iridium STL will provide a resilient timing sync service to data center facilities across the U.S. MCLEAN, Va., April 9, 2024 /PRNewswire/ -- Iridium Communications Inc. (NASDAQ: IRDM), a leading provider of global voice and data satellite communications, today announced a n...

2024-04-09 19:01 2806

Altair Wins 2024 Google Cloud North America Partner of the Year Award for Diversity, Equity, and Inclusion

Award recognizes Google Cloud partner that best prioritized DEI initiatives to transform and strengthen their organization TROY, Mich., April 9, 2024 /PRNewswire/ -- Altair (Nasdaq: ALTR), a global leader in computational intelligence, announced that it has received the 2024 Google Cloud North Am...

2024-04-09 19:00 2440

LyondellBasell demonstrates progress toward industry leadership in 2023 sustainability report

HOUSTON and ROTTERDAM, Netherlands, April 9, 2024 /PRNewswire/ -- LyondellBasell (NYSE: LYB) today published its annual sustainability report titled, Everyday Sustainability. The publication offers an in-depth review of the company's progress over the last year toward establishing itself as an i...

2024-04-09 18:30 4971

Ping An receives Low Risk ESG rating from Sustainalytics Still #1 in Mainland China's insurance sector

HONG KONG and SHANGHAI, April 9, 2024 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEX: 2318 / 82318; SSE: 601318) has again received a "Low Risk" ESG Risk Rating from Sustainalytics, ranked first in Mainland China's insuranc...

2024-04-09 17:34 5165

Fibocom's 5G Premium Smart Module SC171 Awarded as the Best-in-Show Embedded Computing Design at Embedded World 2024

NUREMBERG, Germany, April 9, 2024 /PRNewswire/ -- Fibocom (Stock code: 300638), a global leading provider of IoT (Internet of Things) wireless solutions and wireless communication modules, is proud of winning the Embedded Computing Design's Best in Show award during Embedded World 2024 with groun...

2024-04-09 17:00 2991

Ennostar Strives to Become the Premier Supplier of Comprehensive Automotive Lighting Solutions

HSINCHU, April 9, 2024 /PRNewswire/ -- Ennostar Inc. (TWSE: 3714) will participate in the largest smart display exhibition inTaiwan, Touch Taiwan, from April 24th to April 26th, 2024, unveiling a brand-new appearance under the theme "Drive Enlightening Innovation". This exhibition will showcase En...

2024-04-09 14:01 3030

Waters Launches Alliance iS Bio HPLC System to Help Biopharma QC Labs Increase Efficiency and Reduce Errors

News Summary: * New Alliance™ iS Bio High Performance Liquid Chromatography (HPLC) System helps biopharmaceutical QC laboratories boost efficiency and eliminate up to 40% of common errorsi. * Featuring MaxPeak™ High Performance Surface (HPS) Technology, the new system minimizes unwanted anal...

2024-04-09 14:00 3703

Cognizant Teams with Shopify and Google Cloud To Transform Enterprise Retail

Alliance combines the strength of Shopify's leading commerce platform with Google Cloud's leading AI-infrastructure and delivery by Cognizant's retail technology experts TEANECK, N.J., April 9, 2024 /PRNewswire/ -- Cognizant announced a strategic alliance with Shopify and Google Cloud to drive d...

2024-04-09 12:01 6896

Transcenta Announces Collaboration with Agilent to Develop a Claudin18.2 Companion Diagnostic to Support Osemitamab (TST001) Global Phase III Trial

PRINCETON, N.J. and SUZHOU, China, April 9, 2024 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, and Agilen...

2024-04-09 09:18 3595

Abbisko Completed All Patient Enrollment for The Global Phase III TGCT Trial of Its CSF-1R Inhibitor - Pimicotinib

SHANGHAI, April 8, 2024 /PRNewswire/ -- 9 April 2024 (Beijing Time), Abbisko Therapeutics Co., Ltd. (Abbisko Therapeutics) announced the completion of patient enrollment for its pivotal Phase III trial, MANEUVER (ABSK021-301) STUDY, for evaluating the efficacy and safety of pimicotinib in patient...

2024-04-09 08:30 2627